CN Patent

CN115605492B — 核苷酸前药化合物

Assigned to Ligand Pharmaceutical Co ltd · Expires 2025-09-16 · 1y expired

What this patent protects

本文提供核苷酸前药化合物、其制备及其用途，诸如治疗病毒感染疾病或病症。

USPTO Abstract

本文提供核苷酸前药化合物、其制备及其用途，诸如治疗病毒感染疾病或病症。

Drugs covered by this patent

Patent Metadata

Patent number
CN115605492B
Jurisdiction
CN
Classification
—
Expires
2025-09-16
Drug substance claim
No
Drug product claim
No
Assignee
Ligand Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.